Skip to main content

AMGEN INC (AMGN) Stock Forecast 2025 - AI Price Prediction & Analysis


AMGEN INC (AMGN) AI Stock Price Forecast & Investment Analysis

AMGEN INC Stock Price Chart and Technical Analysis

Loading AMGEN INC interactive price chart and technical analysis...

AMGEN INC (AMGN) - Comprehensive Stock Analysis & Investment Research

Deep dive into AMGEN INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AMGEN INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For AMGEN INC: AMGEN INC operates in the Life Sciences sector, positioning it as a large-cap market leader.

AMGEN INC (Stock Symbol: AMGN) is a leading company in the Life Sciences sector , specifically operating within the Biological Products, (No Diagnostic Substances) industry.

The organization employs approximately 22000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing AMGEN INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMGEN INC: With $34917M in annual revenue and 85.8% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $34917 million generating a 85.8% net profit margin .

Market Capitalization: $159235 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 111.7% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AMGEN INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For AMGEN INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AMGEN INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: AMGEN INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For AMGEN INC: Strong free cash flow generation demonstrates exceptional operational efficiency.

AMGEN INC strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $8417 million annually, complemented by impressive 14.7% year-over-year cash flow growth.

The company maintains a healthy 315.5% gross margin, indicating strong pricing power and operational efficiency.

AMGEN INC (AMGN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AMGEN INC stock analysis.

Loading AMGEN INC comprehensive fundamental analysis and insider trading data...

Deep dive into AMGEN INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AMGEN INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AMGEN INC: With a P/E ratio of 24.06, the market moderately values the company's earnings.

P/E Ratio 24.06x
P/B Ratio 21.44x
Market Cap $159235M
Dividend Yield 0.02%
EPS $12.32
Book Value/Share $13.80
Revenue/Share $64.87
FCF/Share $17.25
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AMGEN INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMGEN INC: An ROE of 111.7% demonstrates excellent shareholder value creation.

ROE 111.7%
ROA 9.4%
ROIC 17.0%
Gross Margin 315.5%
Operating Margin 100.2%
Net Margin 85.8%
EBT Margin 24.8%
Tax Rate 12.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AMGEN INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AMGEN INC: A current ratio of 1.44 shows adequate liquidity.

Current Ratio 1.44x
Quick Ratio 0.90x
D/E Ratio 39.31x
Financial Leverage 64.62x
Interest Coverage 6.4x
Working Capital $9491M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AMGEN INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AMGEN INC: Free cash flow of $8417M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $9321M
Free Cash Flow $8417M
Capital Spending $-904M
OCF Growth YoY 14.7%
FCF Growth YoY 15.9%
FCF/Sales 32.0%
CapEx/Sales 3.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AMGEN INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AMGEN INC: An asset turnover of 0.43x suggests room for improvement in asset utilization.

Asset Turnover 0.43x
Receivables Turnover 5.5x
Inventory Turnover 1.6x
Fixed Assets Turnover 5.3x
Days Sales Outstanding 66 days
Days Inventory 236 days
Payables Period 78 days
Cash Conversion Cycle 223 days
Understanding Financial Statement Data

What these metrics mean: Key figures from AMGEN INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AMGEN INC: With annual revenue of $34917M, AMGEN INC operates at significant scale.

Income Statement ($ Millions)
Total Revenue $34917M
R&D Expense $18M
SG&A Expense $20M
Cost of Goods Sold $12858M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 31%
Cash & Short-term Investments 11%
Total Liabilities 98%
Short-term Debt 1%
Accounts Receivable 9%
Inventory 7%
Dividend & Shareholder Information
Dividends Per Share $4.38
Payout Ratio 0.6%
Shares Outstanding 538M
Growth Metrics (YoY)
EPS Growth 2.7%

Latest AMGEN INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AMGEN INC (AMGN) stock price and investment outlook.

, source: Benzinga

In the current market session, Amgen Inc. (NASDAQ: AMGN) share price is at $295.58, after a 0.08% drop. Over the past month, ...

AMGEN INC Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of AMGEN INC against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABOS Unlock Forecast - 30 Days FREE Trial $130M -1.9x 1.1x
ABP Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ACOG Unlock Forecast - 30 Days FREE Trial $112M x 3.5x
ADAP Unlock Forecast - 30 Days FREE Trial $294M -13.2x -11.8x
ADMA Unlock Forecast - 30 Days FREE Trial $3476M 16.6x 8.7x
ADPT Unlock Forecast - 30 Days FREE Trial $2551M -4.6x 14.2x
AGEN Unlock Forecast - 30 Days FREE Trial $119M -0.5x -0.5x
AIM Unlock Forecast - 30 Days FREE Trial $2M -0.5x -183.3x
AIMI Unlock Forecast - 30 Days FREE Trial $2M x x
ALEC Unlock Forecast - 30 Days FREE Trial $306M -1.2x 4.3x
ALGS Unlock Forecast - 30 Days FREE Trial $89M -19.2x 0.9x
ALLO Unlock Forecast - 30 Days FREE Trial $271M -1.4x 0.8x
AMGN Unlock Forecast - 30 Days FREE Trial $159235M 24.1x 21.4x
APGE Unlock Forecast - 30 Days FREE Trial $3178M -20.5x 4.3x
APTOF Unlock Forecast - 30 Days FREE Trial $3M x x
ARMP Unlock Forecast - 30 Days FREE Trial $115M -1.0x -1.6x
ARTV Unlock Forecast - 30 Days FREE Trial $68M x 0.5x
ATHA Unlock Forecast - 30 Days FREE Trial $150M -0.2x 4.7x
ATRA Unlock Forecast - 30 Days FREE Trial $166M 28.6x -1.1x
AURA Unlock Forecast - 30 Days FREE Trial $367M -4.9x 2.1x
AUTL Unlock Forecast - 30 Days FREE Trial $442M x 1.3x
AVXL Unlock Forecast - 30 Days FREE Trial $792M -17.3x 8.7x
BCLI Unlock Forecast - 30 Days FREE Trial $7M -4.9x -0.9x
BDTX Unlock Forecast - 30 Days FREE Trial $235M 16.3x 1.8x
BEAM Unlock Forecast - 30 Days FREE Trial $2617M -12.6x 2.5x
BIIB Unlock Forecast - 30 Days FREE Trial $20870M 13.6x 1.4x
CABA Unlock Forecast - 30 Days FREE Trial $212M -1.6x 1.2x
CCCC Unlock Forecast - 30 Days FREE Trial $160M -2.6x 0.9x
CELZ Unlock Forecast - 30 Days FREE Trial $9M -3.4x 1.3x
CERO Unlock Forecast - 30 Days FREE Trial $1M x -196.2x
CGEN Unlock Forecast - 30 Days FREE Trial $173M x 3.4x
CGON Unlock Forecast - 30 Days FREE Trial $3141M x 4.7x
CGTX Unlock Forecast - 30 Days FREE Trial $119M -0.5x 16.9x
CHRS Unlock Forecast - 30 Days FREE Trial $194M 1.1x 1.6x
CLDI Unlock Forecast - 30 Days FREE Trial $5M -0.9x 3.0x
CMPX Unlock Forecast - 30 Days FREE Trial $586M -4.8x 6.3x
CRBU Unlock Forecast - 30 Days FREE Trial $232M -1.5x 1.4x
CRDF Unlock Forecast - 30 Days FREE Trial $147M -4.0x 2.5x
CRIS Unlock Forecast - 30 Days FREE Trial $16M -0.3x -2.9x
CRSP Unlock Forecast - 30 Days FREE Trial $6048M -12.1x 3.5x
CVM Unlock Forecast - 30 Days FREE Trial $51M -0.9x 7.3x
DTIL Unlock Forecast - 30 Days FREE Trial $65M -2.2x 1.9x
ELUT Unlock Forecast - 30 Days FREE Trial $40M -1.4x -0.1x
ENGN Unlock Forecast - 30 Days FREE Trial $429M 3.7x 2.1x
ENTX Unlock Forecast - 30 Days FREE Trial $120M 8.5x 7.0x
ESLA Unlock Forecast - 30 Days FREE Trial $48M -3.1x -16.9x
EXEL Unlock Forecast - 30 Days FREE Trial $10592M 17.6x 5.2x
EXOZ Unlock Forecast - 30 Days FREE Trial $109M x 15.0x
FATE Unlock Forecast - 30 Days FREE Trial $194M -1.3x 0.7x
FDMT Unlock Forecast - 30 Days FREE Trial $497M -3.0x 1.2x
FENC Unlock Forecast - 30 Days FREE Trial $238M 1758.3x -39.7x
FNCH Unlock Forecast - 30 Days FREE Trial $20M -0.1x 1.4x
FTII Unlock Forecast - 30 Days FREE Trial $-26M x -0.7x
FTIIU Unlock Forecast - 30 Days FREE Trial $-26M x -0.8x
GILD Unlock Forecast - 30 Days FREE Trial $146370M 23.2x 7.4x
GLUE Unlock Forecast - 30 Days FREE Trial $832M 34.4x 3.1x
GNTA Unlock Forecast - 30 Days FREE Trial $59M x 4.8x
GPLB Unlock Forecast - 30 Days FREE Trial $M x x
HALO Unlock Forecast - 30 Days FREE Trial $7866M 14.1x 23.6x
HLVX Unlock Forecast - 30 Days FREE Trial $105M -0.6x 0.7x
HUMA Unlock Forecast - 30 Days FREE Trial $244M -3.3x 60.2x
IKT Unlock Forecast - 30 Days FREE Trial $145M -1.0x 1.8x
IMCR Unlock Forecast - 30 Days FREE Trial $1686M x 4.3x
IMVT Unlock Forecast - 30 Days FREE Trial $2957M -14.5x 4.9x
INBX Unlock Forecast - 30 Days FREE Trial $502M -6.8x 7.3x
INKT Unlock Forecast - 30 Days FREE Trial $56M -1.5x -1.4x
INMB Unlock Forecast - 30 Days FREE Trial $49M -2.5x 1.7x
INTS Unlock Forecast - 30 Days FREE Trial $8M -2.2x 3.7x
IOVA Unlock Forecast - 30 Days FREE Trial $737M -4.5x 1.1x
IPSC Unlock Forecast - 30 Days FREE Trial $49M -0.7x 0.2x
IVVD Unlock Forecast - 30 Days FREE Trial $211M -0.4x 4.9x
JSPR Unlock Forecast - 30 Days FREE Trial $39M -3.2x 1.7x
KLRS Unlock Forecast - 30 Days FREE Trial $83M x 1.6x
KLTO Unlock Forecast - 30 Days FREE Trial $31M x 2.9x
KOD Unlock Forecast - 30 Days FREE Trial $627M -2.5x 8.9x
KRYS Unlock Forecast - 30 Days FREE Trial $5448M 37.1x 5.2x
KYMR Unlock Forecast - 30 Days FREE Trial $4266M -17.8x 4.4x
KYTX Unlock Forecast - 30 Days FREE Trial $287M x 1.6x
LADX Unlock Forecast - 30 Days FREE Trial $M x x
LCTX Unlock Forecast - 30 Days FREE Trial $369M -4.7x 7.6x
LENZ Unlock Forecast - 30 Days FREE Trial $1154M -6.7x 5.6x
LIMN Unlock Forecast - 30 Days FREE Trial $0M x x
LXEO Unlock Forecast - 30 Days FREE Trial $445M -0.4x 3.2x
MAZE Unlock Forecast - 30 Days FREE Trial $1216M x 4.6x
MGX Unlock Forecast - 30 Days FREE Trial $107M x 0.6x
MRNA Unlock Forecast - 30 Days FREE Trial $10557M -3.2x 1.1x
NBIX Unlock Forecast - 30 Days FREE Trial $13614M 39.1x 5.1x
NMRA Unlock Forecast - 30 Days FREE Trial $305M -3.9x 1.7x
NVAX Unlock Forecast - 30 Days FREE Trial $1312M 3.1x 34.9x
PASG Unlock Forecast - 30 Days FREE Trial $27M -0.6x 0.7x
PCVX Unlock Forecast - 30 Days FREE Trial $5659M -20.4x 1.8x
PHGE Unlock Forecast - 30 Days FREE Trial $16M 1.5x 0.8x
PLUR Unlock Forecast - 30 Days FREE Trial $4M -1.4x -9.1x
PLX Unlock Forecast - 30 Days FREE Trial $183M 29.2x 3.7x
PRME Unlock Forecast - 30 Days FREE Trial $764M -1.5x 12.6x
PROK Unlock Forecast - 30 Days FREE Trial $184M x 0.0x
QGEN Unlock Forecast - 30 Days FREE Trial $10816M x 3.0x
QNCX Unlock Forecast - 30 Days FREE Trial $100M -1.7x 8.5x
RGNX Unlock Forecast - 30 Days FREE Trial $562M -1.8x 2.6x
RLAY Unlock Forecast - 30 Days FREE Trial $1134M -2.0x 1.7x
RXRX Unlock Forecast - 30 Days FREE Trial $2748M -4.7x 3.0x
SANA Unlock Forecast - 30 Days FREE Trial $1028M -2.1x 8.4x
SCNI Unlock Forecast - 30 Days FREE Trial $8720M -287.8x 1109.7x
SGMO Unlock Forecast - 30 Days FREE Trial $160M -1.6x 8.2x
SLXN Unlock Forecast - 30 Days FREE Trial $2M x 18.7x
SRZN Unlock Forecast - 30 Days FREE Trial $118M -0.5x 2.5x
STRO Unlock Forecast - 30 Days FREE Trial $68M -1.0x -2.5x
TARA Unlock Forecast - 30 Days FREE Trial $217M -2.1x 1.5x
TARS Unlock Forecast - 30 Days FREE Trial $3201M -12.4x 9.6x
TCBPY Unlock Forecast - 30 Days FREE Trial $15M x 13.6x
TCRX Unlock Forecast - 30 Days FREE Trial $287M -4.6x 1.6x
TECX Unlock Forecast - 30 Days FREE Trial $300M -8.9x 1.1x
TNYA Unlock Forecast - 30 Days FREE Trial $287M -2.5x 2.9x
TRML Unlock Forecast - 30 Days FREE Trial $1231M -3.5x 4.8x
TSHA Unlock Forecast - 30 Days FREE Trial $1385M -3.0x 5.6x
TVGN Unlock Forecast - 30 Days FREE Trial $138M x -29.3x
TWST Unlock Forecast - 30 Days FREE Trial $1856M -12.6x 3.9x
VACH Unlock Forecast - 30 Days FREE Trial $-1443M x 0.0x
VACHU Unlock Forecast - 30 Days FREE Trial $-1454M x 0.0x
VCEL Unlock Forecast - 30 Days FREE Trial $1753M 246.6x 5.7x
VIR Unlock Forecast - 30 Days FREE Trial $806M -2.0x 0.9x
VOR Unlock Forecast - 30 Days FREE Trial $3924M -0.6x 3.9x
VXRT Unlock Forecast - 30 Days FREE Trial $80M -0.9x 2.4x
VYGR Unlock Forecast - 30 Days FREE Trial $293M 570.6x 1.2x
ZIVO Unlock Forecast - 30 Days FREE Trial $50M -31.3x -2.0x

Frequently Asked Questions - AMGEN INC Stock Forecast

How accurate are AMGEN INC stock predictions?

Our AI model demonstrates 62% historical accuracy for AMGN predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence AMGEN INC stock price forecasts?

Our analysis considers AMGEN INC's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AMGEN INC a good investment in 2025?

Based on our AI analysis, AMGEN INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AMGEN INC forecasts updated?

AMGEN INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AMGEN INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AMGEN INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...